SEC Form 4 · accession 0001209191-15-062187
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Amit Sachdev
Officer — EVP, Policy, Access & Value
Period of report
Jul 21, 2015
Accepted (ET)
Jul 23, 2015 · 4:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875320
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $131.89 | Jul 21, 2015 | A | 34,000 | A | — | Jul 20, 2025 | Common Stock | 34,000 | 34,000 | D |
Explanation of responses
- F1The option vests in 16 quarterly installments from 07/21/2015.